MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Peter Dannenbaum
Peter DannenbaumMERCK & CO

Peter Dannenbaum

Investors Relations Manager at MERCK & CO

Manager

Deal Bio

Total Deals15
Valued Deals13
Total Value£34,126M
Avg. Deal Size£2,625M

Market Context

Expertise (15)

Key Relationships

Sort

United States
Biotechnology
Cross BorderAcquisitionMajorityPublicTender Offer
Arqule

target

Arqule

Merck Kgaa

bidder

Merck Kgaa

£2,054m

62 dealmakers

United StatesUnited States
Pharmaceuticals
MajoritySpin OffPrivateDomesticPrivate Equity
Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)

target

Merck & Co (women’s Health, Trusted Legacy Brands, And Biosimilars Businesses)

Institutional Investors

bidder

Institutional Investors

£5,390m

17 dealmakers

Austria
Biotechnology
AcquisitionPrivateMajorityCross BorderDisposalVenture CapitalPrivate Equity
Themis Bioscience

target

Themis Bioscience

Merck & Co

bidder

Merck & Co

value n/a

37 dealmakers

United States
Biotechnology
Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity
Velosbio

target

Velosbio

Merck & Co

bidder

Merck & Co

£2,116m

55 dealmakers

United States
Biotechnology
AcquisitionPrivateDomesticMajorityPrivate Equity
ONCOIMMUNE

target

ONCOIMMUNE

Merck & Co

bidder

Merck & Co

£319m

10 dealmakers

United States
Biotechnology
AcquisitionPublicDomesticMajorityTender Offer
Pandion Therapeutics

target

Pandion Therapeutics

Merck & Co

bidder

Merck & Co

£1,308m

28 dealmakers

United States
Medical Equipment
AcquisitionDomesticMajorityPrivate
Alydia Health

target

Alydia Health

Organon & Co

bidder

Organon & Co

£174m

15 dealmakers

United States
Biotechnology
DomesticMajorityAcquisitionPublic
Acceleron Pharma

target

Acceleron Pharma

Merck & Co

bidder

Merck & Co

£8,528m

80 dealmakers

United States
Electronic Equipment: Other
DomesticAcquisitionPrivateMajority
VENCE

target

VENCE

Merck Animal Health

bidder

Merck Animal Health

value n/a

4 dealmakers

United States
Pharmaceuticals
DomesticPublicMajorityAcquisitionTender Offer
Imago Biosciences

target

Imago Biosciences

Merck & Co

bidder

Merck & Co

£1,135m

42 dealmakers

United States
Biotechnology
DomesticAcquisitionMajorityPublic
Prometheus Biosciences

target

Prometheus Biosciences

Merck & Co

bidder

Merck & Co

£8,698m

50 dealmakers

United States
Pharmaceuticals
AcquisitionDomesticPrivateMajority
Caraway Therapeutics

target

Caraway Therapeutics

Merck & Co

bidder

Merck & Co

£488m

7 dealmakers

United States
Biotechnology
AcquisitionDomesticMajorityPublic
Harpoon Therapeutics

target

Harpoon Therapeutics

Merck & Co

bidder

Merck & Co

£534m

62 dealmakers

United States
Health Care Services
AcquisitionMajorityDomesticPrivate
Elanco Animal Health (aqua Business)

target

Elanco Animal Health (aqua Business)

Merck Animal Health

bidder

Merck Animal Health

£1,028m

58 dealmakers

United States
Biotechnology
MajorityDomesticPrivate EquityAcquisitionPrivate
EYEBIOTECH

target

EYEBIOTECH

Merck & Co

bidder

Merck & Co

£2,348m

23 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US